Abstract
Myocardial cell death is a key element in the pathogenesis and progression of various etiological cardiomyopathies such as ischemia-reperfusion, toxic exposure, and various chronic diseases including myocardial infarction, atherosclerosis, and endothelial dysfunction. Myocardial cell death is also observed in the hearts of diabetic patients and antimal models; however, its importance in the development of diabetic cardiomyopathy is not completely understood. The goal of this review is to summarize our current understanding of the characteristics of diabetes-induced myocardial cell death. In the search of themechanisms by which diabetes induces myocardial cell death, multiple cell death pathways have been proposed. Reactive oxygen and nitrogen species accumulation plays a critical role in the cell death by antioxidants or inhibitors for apoptosis-specific signaling pathways results in a significant prevention of diabetic cardiotoxicity, suggesting that cell death in diabetic subjects plays an important role in the development of diabetic cardiomyopathy.
Similar content being viewed by others
References
Swynghedauw, B. (1999). Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79:215–262.
Kang, Y.J. (2001). Molecular and cellular mechanisms of cardiotoxicity. Environ. Health Perspect. 109(Suppl 1):27–34.
Teiger, E., Than, V.D., Richard, L., Wisnewsky, C., Tea, B.S., Gaboury, L., Tremblay, J., Schwartz, K. and Hamet, P. (1996). Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97:2891–2897.
Narula, J., Kolodgie, F.D. and Virmani, R. (2000). Apoptosis and cardiomyopathy. Curr. Opin. Cardiol. 15:183–188.
Nerheim, P., Krishnan, S.C., Olshansky, B. and Shivkumar, K. (2001). Apoptosis in the genesis of cardiac rhythm disorders. Cardiol. Clin. 19:155–163.
Tomei, L.D. and Umansky, S.R. (2001). Apoptosis and the heart: A brief review. Ann. NY Acad. Sci. 946:160–168.
Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O’Connell, J., et al. (1996). Report of the 1995 World health organization/International Society and Federation of Cardiology Task force on the definition and classification of cardiomyopathies. Circulation 93:841–842.
Davies, M.J. (2000). The cardiomyopathies: An overview. Heart 83:469–474.
Francis, G.S. (2001). Editorial. Diabetic cardiomyopathy: Fact or friction? Heart 85:247–248.
Sowers, J.R., Epstein, M., and Frohlich, E.D. (2001). Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 37:1053–1059.
Timmis, A.D. (2001). Diabetic heart disease: Clinical considerations. Heart 85:463–469.
Alici, B., Gumustas, M.K., Ozkara, H., Akkus, E., Demirel, G., Yencilek, F., and Hattat, H. (2000). Apoptosis in the erectile tissues of diabetic and healthy rats. Br. J. Urol. Int. 85:326–329.
Moley, K.H. (2001). Hyperglycemia and apoptosis: Mechanisms for congenital malformations and pregnancy loss in diabetic woman. Trends Endocr. Metab. 12:78–82.
Srinivasan, S., Stevens, M., and Wiley, J.W. (2000). Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49:1932–1938.
Barber, A.J., Lieth, E., Khin, S.A., Antonetti, D.A., Buchanan, A.G., and Gardner, T.W. (1998). Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102:783–791.
Kang, B.P., Frencher, S., Reddy, V., Kessler, A., Malhotra, A., and Meggs, L.G. (2003). High glucose promotes mesangial cell apoptosis by an oxidant dependent mechanism. Am. J. Physiol. Renal Physiol. 284:F455-F466.
Li, Z.G., Zhang, W., Grunberger, G., and Sima, A.A. (2002). Hippocampal neuronal apoptosis in type-1 diabetes. Brain Res. 946:221–231.
Russell, J.W., Golovoy, D., Vincent, A.M., Mahendru, P., Olzmann, J.A., Mentzer, A., and Feldman, E.L. (2002). High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 16:1738–1748.
Sainio-Pollanen, S., Henriksen, K., Parvinen, M., Simell, O., and Pollanen, P. (1997). Stage-specific degeneration of germ cells in the seminiferous tubules of non-obese diabetic mice. Int. J. Androl. 20:243–253.
Cai, L., Chen, S., Evans, T., Deng, D.X., Mukherjee, K., and Chakrabarti, S. (2000). Apoptotic germ-cell death and testicular damage in experimental diabetes: Prevention by endothelin antagonism. Urol. Res. 28:342–347.
Feuerstein, G.Z., and Young, P.R. (2000). Apoptosis in cardiac diseases: Stress- and mitogen-activated signaling pathways. Cardiovasc. Res. 45:560–569.
Cai, L., and Kang, Y.J. (2001). Oxidative stress and diabetic cardiomyopathy: A brief review. Cardiovasc. Toxicol. 1:181–193.
Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E.H., Anversa, P., Leri, A., and Kajstura, J. (2000). Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab. Invest. 80:513–527.
Chen, S., Evans, T., Mukherjee, K., Karmazyn, M., and Chakrabarti, S. (2000). Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J. Mol. Cell. Cardiol. 32:1621–1629.
Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y., and Kang, Y.J. (2002). Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51:1938–1948.
Kajstura, J., Fiordaliso, F., Andreoli, A.M., Li, B., Chimenti, S., Medow, M.S., et al. (2001). IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50: 1414–1424.
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B. and Anversa, P. (2000). Myocardial cell death in human diabetes. Circ. Res. 87:1123–1132.
Baumgartner-Parzer, S.M., Wagner, L., Pettermann, M., Grillari, J., Gessl, A., and Waldhausl, W. (1995). High-glucose—triggered apoptosis in cultured endothelial cells. Diabetes 44:1323–1327.
Wu, Q.D., Wang, J.H., Fennessy, F., Redmond, H.P., and Bouchier-Hayes, D. (1999). Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 277:C1229-C1238.
Chi, M.M., Pingsterhaus, J., Carayannopoulos, M., and Moley, K.H. (2000). Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J. Biol. Chem. 275:40252–40257.
Ho, F.M., Liu, S.H., Liau, C.S., Huang, P.J., and Lin-Shiau, S.Y. (2000). High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101:2618–2624.
Peiro, C., Lafuente, N., Matesanz, N., Cercas, E., Llergo, J.L., Vallejo, S., et al. (2001). High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br. J. Pharmacol. 133:967–974.
Zou, M.H., Shi, C., and Cohen, R.A. (2002). High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198–203.
Fiordaliso, F., Leri, A., Cesselli, D., Limana, F., Safai, B., Nadal-Ginard, B., et al. (2001). Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363–2375.
Shizukuda, Y., Reyland, M.E., and Buttrick, P.M. (2002). Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 282:H1625-H1634.
Zhou, Y.T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., and Unger, R.H. (2000). Lipotoxic heart disease in obese rats: Implications for human obesity. Proc. Natl. Acad. Sci. USA 97:1784–1789.
Chiu, H.C., Kovacs, A., Ford, D.A., Hsu, F.F., Garcia, R., Herrero, P., Saffitz, J.E., and Schaffer, J.E. (2001). A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107:813–822.
Unger, R.H., and Orci, L. (2001). Diseases of liporegulation: New perspective on obesity and related disorders. FASEB J. 15:312–321.
Finck, B.N., Lehman, J.J., Leone, T.C., Welch, M.J., Bennett, M.J., Kovacs, A., et al. (2002). The cardiac phenotype induced by PPARa overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109:121–130.
Pulkki, K.J. (1997) Cytokines and cardiomyocyte death. Ann. Med. 29:339–343.
Ginsberg, H.N., and Tuck, C. (2001). Diabetes and dyslipidemia. In: Johnstone, M.J. and Veves, A. (eds). Diabetes and Cardiovascular Disease. Totowa, NJ: Humana Press, pp 131–147.
Lopaschuk, G.D. (1996). Fatty acid metabolism in the heart following diabetes. In: Chatham, J.C., Forder, J.R., and McNeill, J.H. (eds). The Heart in Diabetes. Norwell, MA: Kluwer Academic, pp. 215–251.
Rosen, P., Nawroth, P.P., King, G., Moller, W., Tritschler, H.J., and Packer, L. (2001). The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17:189–212.
Murthy, V.K. and Shipp, J.C. (1997). Accumulation of myocardial triglycerides ketotic diabetes; evidence for increased biosynthesis. Diabetes 26:222–229.
Paulson, D.J. and Crass, M.F. III. (1982). Endogenous triacylglycerol metabolism in diabetic heart. Am. J. Physiol. 242:H1084-H1094.
Chattopadhyay, J., Thompson, E.W., and Schmid, H.H. (1990). Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats. Lipids 25:307–310.
Avogaro, A., Nosadini, R., Doria, A., Fioretto, P., Velussi, M., Vigorito, C., et al. (1990). Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am. J. Physiol. 258:E606-E618.
Sparagna, G.C., Hickson-Bick, D.L., Buja, L.M., and McMillin, J.B. (2000). A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 279:H2124-H2132.
Hickson-Bick, D.L., Buja, M.L., and McMillin, J.B. (2000). Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J. Mol. Cell. Cardiol. 32: 511–519.
Kong, J.Y., and Rabkin, S.W. (2000). Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: Prevention by cyclosporin A. Biochim. Biophys. Acta 1485:45–55.
Listenberger, L.L., Ory, D.S., and Schaffer, J.E. (2001). Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276:14890–14895.
Hickson-Bick, D.L., Sparagna, G.C., Buja, L.M., McMillin, J.B. (2002). Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am. J. Physiol. Heart Circ. Physiol. 282:H656-H664.
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., et al. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 106:2067–2072.
Meldrum, D.R. (1998). Tumor necrosis factor in the heart. Am. J. Physiol. 274:R577-R595.
Sack, M.N. (2002). Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol. Ther. 94:123–135.
Grimble, R.F. (2002). Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5:551–559.
Giroir, B.P., Johnson, J.H., Brown, T., Allen, G.L., and Beutler, B. (1992). The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90:693–698.
Depre, C., Young, M.E., Ying, J., Ahuja, H.S., Han, Q., Garza, N., et al. (2000). Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J. Mol. Cell. Cardiol. 32:985–996.
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., et al. (1998). Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97:1375–1381.
Song, W., Lu, X., and Feng, Q. (2000). Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc. Res. 45:595–602.
Klein, J.B., Wang, G., Zhou, Z., Burdi, A., and Kang, Y.J. (2002). Inhibition of tumor necrosis factor-a-dependent cardiomyocyte apoptosis by metallothionein. Cardiovasc. Toxicol. 2:209–217.
Scarabelli, T.M., Stephanou, A., Pasini, E., Comini, L., Raddino, R., Knight, R.A., and Latchman, D.S. (2002). Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ. Res. 90:745–748.
Nakagami, H., Morishita, R., Yamamoto, K., Yoshimura, S.I., Taniyama, Y., Aoki, M., et al. (2001). Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50:1472–1481.
Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K., and Harrison, D.G. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1916–1923.
Berry, C., Hamilton, C.A., Brosnan, M.J., Magill, F.G., Berg, G.A., McMurray, J.J., et al. (2000). Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101:2206–2212.
Monkemann, H., De Vriese, A.S., Blom, H.J., Kluijtmans, L.A., Heil, S.G., Schild, H.H., et al. (2002). Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids 23:331–336.
Listenberger, L.L., and Schaffer, J.E. (2002). Mechanisms of lipoapoptosis: Implications for human heart disease. Trends Cardiovasc. Med. 12:134–138.
Ohuwa, T., Sato, Y., and Naoi, M. (1995). Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci. 56:1789–1798.
Pennathur, S., Wagner, J.D., Leeuwenbergh, C., Litwak, K.N., and Heinecke, J.W. (2001). A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J. Clin. Invest. 107: 853–860.
Cai, L., Sun, X., Li, Y., Wang, L., and Kang, Y.J. (2003). Inhibition of peroxynitrite-induced damage is involved in metallothionein prevention of diabetic cardiotoxicity. Toxicol. Sci. 72(Suppl. 1):36.
Desco, M.C., Asensi, M., Marquez, R., Martinez-Valls, J., Vento, M., Pallardo, F.V., et al. (2002). Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes 51:1118–1124.
Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790.
Tanaka, Y., Konno, N., and Kako, K.J. (1992). Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc. Res. 26:409–414.
Flarsheim, C.E., Grupp, I.L., and Matlib, M.A. (1996). Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am. J. Physiol. 271:H192-H202.
Aikawa, R., Nitta-Komatsubara, Y., Kudoh, S., Takano, H., Nagai, T., Yazaki, Y., et al. (2002). Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-alpha. Cytokine 18:179–183.
Bajt, M.L., Ho, Y.S., Vonderfecht, S.L., and Jaeschke, H. (2002). Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: Studies with glutathione peroxidase-deficient mice. Antioxid. Redox Signal 4:733–740.
Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., et al. (2002). Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 34:233–240.
Machida, Y., Kubota, T., Kawamura, N., Funakoshi, H., Ide, T., Utsumi, H., et al. (2003). Overexpression of tumor necrosis factor-α increases production of hydroxyl radical in murine myocardium. Am. J. Physiol. Heart Circ. Physiol. 284:H449-H455.
Kulisz, A., Chen, N., Chandel, N.S., Shao, Z., and Schumacker, P.T. (2002). Mitochondrial ROS initiate phosphor-ylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L1324-L1329.
Pacher, P., Liaudet, L., Soriano, F.G., Mabley, J.G., Szabo, E., and Szabo, C. (2002). The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51:514–521.
Kajstura, J., Cheng, W., Reiss, K., Clark, W.A., Sonnenblick, E.H., Krajewski, S., et al. (1996). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74:86–107.
Cai, L. and Kang, Y.J. (2001). Metallothionein prevents diabetic cardiomyopathy. Toxicol. Sci. 60(Suppl. 1):13.
Cai, L., Li, W., Sun X., Li, Y., and Kang, Y.J. (2002). Prevention of diabetic cardiomyopathy by metallothionein through suppression of hyperglycemia-induced oxidative stress and cell death. Toxicol. Sci. 66(Suppl. 1):288.
Kang, Y.J. (1999). The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222: 263–273.
Cai, L., Klein, J.B., and Kang, Y.J. (2000). Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J. Biol. Chem. 275:38957–38960.
Dai, S. and McNeill, J.H. (1995). Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Diabetes Res. Clin. Pract. 27:11–18.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, L., Kang, Y.J. Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3, 219–228 (2003). https://doi.org/10.1385/CT:3:3:219
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CT:3:3:219